InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by SNODGRASS H. RALPH. Officer active across 1 companies, notably VistaGen Therapeutics, Inc.. Cumulatively, 8 filings have been published. Total volume traded: €17k. The latest transaction was disclosed on 31 December 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
€5,3033,623 shares@ €1.46360.021% mcap13.5% of flow
Common Stock
SEC:0001415889-22-000038:0·
€5,3033,623 shares@ €1.46360.021% mcap27.0% of flow
Common Stock
SEC:0001415889-22-000038·
0740 shares0
Common Stock
SEC:0001415889-21-004226·
0740 shares0
Common Stock
SEC:0001415889-21-004226:0·
€8,7433,750 shares@ €2.33140.035% mcap44.6% of flow
Common Stock
SEC:0001415889-21-004002·
Ideal exit: 14 May 2022 (T+270)
€8,7433,750 shares@ €2.33140.035% mcap22.3% of flow
Common Stock
SEC:0001415889-21-004002:0·
Ideal exit: 14 May 2022 (T+270)
€5,5673,391 shares@ €1.64170.022% mcap28.4% of flow
Common Stock
SEC:0001415889-21-003389·
€5,5673,391 shares@ €1.64170.022% mcap14.2% of flow
Common Stock
SEC:0001415889-21-003389:0·
8 of 8 declarations
About SNODGRASS H. RALPH
H. Ralph Snodgrass is a director at VistaGen Therapeutics, Inc.
